Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M [Yahoo! Finance]
Indivior PLC - Ordinary Shares (INDV)
Company Research
Source: Yahoo! Finance
Indivior PLC (NASDAQ:INDV) is a pharmaceutical company specializing in treatments for opioid use disorder (OUD), with its core products SUBLOCADE, a once-monthly buprenorphine injection, and SUBOXONE film forming the backbone of its revenue. In September 2025, the corporation reported strong Q2 results, with total net revenue of $302 million. SUBLOCADE sales rose 9% year-over-year to $209 million, driven by a 20% increase in U.S. volumes versus Q1 2025. The company subsequently raised its full-year 2025 revenue guidance to $1.03–$1.08 billion, up from $955 million–$1.025 billion, while adjusted EBITDA guidance increased to $275–$300 million, positioning Indivior among the best performing stocks in its sector. These results reflect progress on the “Indivior Action Agenda,” a strategic initiative focused on expanding SUBLOCADE in the U.S. and streamlining operations to boost efficiency and cash generation. The company also consolidated its stock listing to Nasdaq in July 2025, emph
Show less
Read more
Impact Snapshot
Event Time:
INDV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INDV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INDV alerts
High impacting Indivior PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
INDV
News
- Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Indivior (NASDAQ:INDV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Indivior Concludes Legacy U.S. Department of Justice Matter [Yahoo! Finance]Yahoo! Finance
- Indivior Concludes Legacy U.S. Department of Justice MatterPR Newswire
INDV
Earnings
- 10/30/25 - Beat
INDV
Sec Filings
- 11/20/25 - Form 8-K
- 11/14/25 - Form 8-K
- 11/13/25 - Form SCHEDULE
- INDV's page on the SEC website